תרכובות פירידוניל גואנידין המעכבות f1f0–atpase
- 专利权人:
- LYCERA CORPORATION
- 发明人:
- 申请号：
- IL22679013
- 公开号：
- IL226790A
- 申请日:
- 2013.06.06
- 申请国别(地区):
- IL
- 年份:
- 2017
- 代理人:
- 摘要：
- The invention provides pyridonyl guanidine compounds that inhibit F1F0-ATPase, and methods of using pyridonyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- AZOLOPYRIMIDINES FOR TREATMENT OF CANCER DISEASES
- Azolopyrimidine for Treatment of Cancer-Related Disorders
- 經取代的８-雜芳基黃嘌呤
- Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
- Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
